U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855654) titled 'Promoting Resilience in Women With Breast Cancer (PRISM -MBC)' on Feb. 26.
Brief Summary: This pilot interventional study evaluates the change from baseline to post-intervention in resilience and other patient-reported outcomes for individuals with a recent diagnosis of metastatic breast cancer (MBC) participating in the Promoting Resilience in Women with Breast Cancer (PRISM) intervention, overall and stratified by race, and to evaluate the feasibility and acceptability of the PRISM intervention in the MBC population.
Black women with MBC have shorter survival from the time of metastatic diagnosis to death, compared to White women...